Skip to main content
Bavarian Nordic logo

Bavarian Nordic — Investor Relations & Filings

Ticker · BAVA ISIN · DK0015998017 LEI · 2138006JCDVYIN6INP51 CO Manufacturing
Open in API
Filings indexed 2,303 across all filing types
Latest filing 2024-04-29 Regulatory Filings
Country DK Denmark
Listing CO BAVA

About Bavarian Nordic

https://www.bavarian-nordic.com/

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a press release from Bavarian Nordic announcing that they have initiated the rolling submission of their registration application for the CHIKV VLP vaccine candidate to the U.S. Food and Drug Administration (FDA). This is an announcement about a regulatory submission process, not the final regulatory filing itself (like a 10-K or AR). Since it is a specific announcement regarding regulatory progress and submission timelines, it fits best under 'Regulatory Filings' (RNS) as a general regulatory announcement, or potentially 'LTR' if it were about legal proceedings, but here it is about product approval. Given the options, RNS serves as the best general category for significant, non-financial regulatory updates that don't fit other specific codes. However, the content is highly specific to the regulatory process of a drug application. Since there is no specific code for 'Regulatory Submission Announcement' other than RNS, and it is not a formal legal proceeding (LTR), RNS is the most appropriate fallback for a significant regulatory update that isn't a core financial report. The document length is short (4660 chars) and it announces an action ('påbegynder' - begins) rather than being the full application document.
2024-04-29 Danish
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is an announcement titled "Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate." It details regulatory progress (BLA submission, Breakthrough Therapy designation) and includes forward-looking statements and contact information, typical of a press release regarding corporate development. It is not a full financial report (10-K, IR), an earnings release (ER), or a transcript (CT). Since it is a specific corporate announcement about regulatory/development progress that doesn't fit neatly into the other specific categories (like M&A, Dividend, or Management Change), it falls best under the general Regulatory Filings category (RNS) as a broad corporate update, although it is highly specific. Given the options, RNS serves as the best fit for a general, non-financial, non-meeting-related regulatory/development update that isn't a specific legal or capital event.
2024-04-29 English
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
Regulatory Filings Classification · 95% confidence The document is a corporate announcement (Selskabsmeddelelse) from Bavarian Nordic regarding the initiation of a rolling submission for a vaccine registration application to the FDA. It is a standard regulatory announcement regarding company operations and product development progress. Since it does not fit into specific categories like financial reports, board changes, or dividend notices, it falls under the general regulatory announcement category.
2024-04-29 Danish
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the initiation of a rolling submission for a Biologics License Application (BLA) with the FDA for a vaccine candidate. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general regulatory/corporate update regarding business operations and regulatory milestones, it falls under the 'Regulatory Filings' (RNS) category.
2024-04-29 English
Director's Dealing 2024
Director's Dealing Classification · 100% confidence The document is titled "Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such." It details specific share acquisitions (vesting of restricted stock units) by members of the Board of Directors (Anders Gersel Pedersen, Peter Kürstein, Frank Verwiel) on April 22, 2024. This content directly corresponds to the definition of Director's Dealing, which reports personal share transactions by company directors and executives.
2024-04-22 English
Director's Dealing 2024
Director's Dealing Classification · 100% confidence The document text is titled 'Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier' (Reporting of transactions in Bavarian Nordic shares by senior employees and their closely associated persons). It details specific share transactions (overdragelse af betingede aktier - transfer of conditional shares) made by board members and senior management on April 22, 2024. This content directly corresponds to the definition of reporting personal share transactions by company directors and executives, which maps to the 'Director's Dealing' category. Code mapping: Director's Dealing corresponds to DIRS.
2024-04-22 Danish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.